BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37384825)

  • 21. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
    Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
    Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case report: Relapsed/refractory extranodal natural killer/T-cell lymphoma nasal type with extensive central nervous system involvement.
    Dapkevičiūtė-Purlienė A; Augustinavičius V; Žučenka A
    Pathol Oncol Res; 2022; 28():1610866. PubMed ID: 36699620
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.
    Kohrt H; Advani R
    Leuk Lymphoma; 2009 Nov; 50(11):1773-84. PubMed ID: 19883307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral T cell lymphoma of the nasopharynx with expansion of EBV-positive B cells masquerading as an extranodal NK/T cell lymphoma, nasal type.
    Kim HN; Kim DS; Jeon MJ; Yu ES; Choi CW; Ko YH
    Virchows Arch; 2022 Jul; 481(1):125-129. PubMed ID: 34997312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
    Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
    Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
    Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
    Wang X; Hu J; Dong M; Ding M; Zhu L; Wu J; Sun Z; Li X; Zhang L; Li L; Wang X; Fu X; Wang G; Chen Q; Zhang M; Zhang X
    Clin Transl Sci; 2021 Jan; 14(1):405-411. PubMed ID: 33045134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research Advances on Extranodal Nasal Type NK/T Cell Lymphoma--Review].
    Yu G; Chen JG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):271-4. PubMed ID: 26913435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
    Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
    Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Rare Case of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Associated With Hemophagocytic Lymphohistiocytosis in a Patient With Recurrent Sinusitis.
    Christensen BR; Kou CJ; Lee LE
    Cureus; 2024 Mar; 16(3):e56237. PubMed ID: 38618451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal involvement by extranodal natural killer T cell lymphoma, nasal type, mimicking Ebstein Barr viral esophagitis in a tonsillar lymphoma patient undergoing chemoradiation therapy.
    Lee SR; Park EK; Won NH; Kim BS
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):149-54. PubMed ID: 20887494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Senda N; Miyagaki T; Oka T; Itoigawa A; Kikuchi K; Kobayashi T; Nakamura F; Kurokawa M; Sugaya M; Sato S
    J Dermatol; 2019 May; 46(5):e161-e163. PubMed ID: 30379350
    [No Abstract]   [Full Text] [Related]  

  • 39. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.
    Asakura T; Ishii M; Kikuchi T; Kameyama K; Namkoong H; Nakata N; Sugita K; Tasaka S; Shimizu T; Hoshino Y; Okamoto S; Betsuyaku T; Hasegawa N
    Medicine (Baltimore); 2016 Mar; 95(11):e3131. PubMed ID: 26986167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
    Suzuki R
    Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.